Searching the Resource Information Network

Our searching services are busy right now. Please try again later

  • Register
X
Forgot Password

If you have forgotten your password you can enter your email here and get a temporary password sent to your email.

X

Leaving Community

Are you sure you want to leave this community? Leaving the community will revoke any permissions you have been granted in this community.

No
Yes

Commensal bacteria-derived signals regulate basophil hematopoiesis and allergic inflammation.

David A Hill | Mark C Siracusa | Michael C Abt | Brian S Kim | Dmytro Kobuley | Masato Kubo | Taku Kambayashi | David F Larosa | Ellen D Renner | Jordan S Orange | Frederic D Bushman | David Artis
Nature medicine | 2012

Commensal bacteria that colonize mammalian barrier surfaces are reported to influence T helper type 2 (T(H)2) cytokine-dependent inflammation and susceptibility to allergic disease, although the mechanisms that underlie these observations are poorly understood. In this report, we find that deliberate alteration of commensal bacterial populations via oral antibiotic treatment resulted in elevated serum IgE concentrations, increased steady-state circulating basophil populations and exaggerated basophil-mediated T(H)2 cell responses and allergic inflammation. Elevated serum IgE levels correlated with increased circulating basophil populations in mice and subjects with hyperimmunoglobulinemia E syndrome. Furthermore, B cell-intrinsic expression of myeloid differentiation factor 88 (MyD88) was required to limit serum IgE concentrations and circulating basophil populations in mice. Commensal-derived signals were found to influence basophil development by limiting proliferation of bone marrow-resident precursor populations. Collectively, these results identify a previously unrecognized pathway through which commensal-derived signals influence basophil hematopoiesis and susceptibility to T(H)2 cytokine-dependent inflammation and allergic disease.

Pubmed ID: 22447074

Research resources used in this publication

None found

Antibodies used in this publication

None found

Associated grants

  • Agency: NIAID NIH HHS, United States
    Id: R01 AI074878
  • Agency: NIAID NIH HHS, United States
    Id: T32-AI060516
  • Agency: NHLBI NIH HHS, United States
    Id: HL107589
  • Agency: NIDDK NIH HHS, United States
    Id: UH2 DK083981
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI095466
  • Agency: NIDDK NIH HHS, United States
    Id: P30 DK050306
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI067946
  • Agency: NIAID NIH HHS, United States
    Id: AI074878
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL111501
  • Agency: NHLBI NIH HHS, United States
    Id: R01 HL107589
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI083480
  • Agency: NHLBI NIH HHS, United States
    Id: HL111501
  • Agency: NIAID NIH HHS, United States
    Id: U01 AI095608
  • Agency: NIAID NIH HHS, United States
    Id: R01 AI061570
  • Agency: NIAID NIH HHS, United States
    Id: F32-AI085828
  • Agency: NIAID NIH HHS, United States
    Id: AI061570
  • Agency: NIAID NIH HHS, United States
    Id: AI067946
  • Agency: NIDDK NIH HHS, United States
    Id: UH2DK083981
  • Agency: NIDDK NIH HHS, United States
    Id: DK50306
  • Agency: NIAID NIH HHS, United States
    Id: R56 AI067946
  • Agency: NIAID NIH HHS, United States
    Id: AI087990
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI060516
  • Agency: NCI NIH HHS, United States
    Id: 2-P30 CA016520
  • Agency: NIAID NIH HHS, United States
    Id: T32 AI060516-05
  • Agency: NIAID NIH HHS, United States
    Id: AI083480
  • Agency: NIAMS NIH HHS, United States
    Id: P30 AR057217
  • Agency: NIAID NIH HHS, United States
    Id: R21 AI087990
  • Agency: NIAMS NIH HHS, United States
    Id: T32 AR007465
  • Agency: NIAID NIH HHS, United States
    Id: AI095608
  • Agency: NIAID NIH HHS, United States
    Id: T32-AI05528
  • Agency: NIAID NIH HHS, United States
    Id: AI095466

Publication data is provided by the National Library of Medicine ® and PubMed ®. Data is retrieved from PubMed ® on a weekly schedule. For terms and conditions see the National Library of Medicine Terms and Conditions.

This is a list of tools and resources that we have found mentioned in this publication.


Genentech (tool)

RRID:SCR_003997

A biotechnology corporation that uses human genetic information to discover, develop, manufacture and commercialize medicines to treat patients with serious or life-threatening medical conditions.

View all literature mentions

BALB/cAnNCrl (tool)

RRID:MGI:2683685

laboratory mouse with name BALB/cAnNCrl from MGI.

View all literature mentions

C57BL/6J (tool)

RRID:IMSR_JAX:000664

Mus musculus with name C57BL/6J from IMSR.

View all literature mentions